文献速递认知障碍与痴呆

老年人血浆p-tau231、p-tau181、PET生物标志物与认知变化

Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults.
PubMed 文献 · Ann Neurol · 2022-02-18

研究在244名有阿尔茨海默病痴呆家族史的认知正常老年人中,检测血浆p-tau231、p-tau181、Aβ40、Aβ42及神经丝轻链,其中129人接受Aβ和tau PET。血浆p-tau231与PETtau和Aβ病理的关联比p-tau181更广泛,Aβ42/40联合p-tau可良好区分Aβ-PET阴性阳性(AUC 0.81-0.86),低Aβ42/40且高p-tau者认知下降更快。

要点

  • 血浆p-tau231与颞叶、顶叶及枕叶皮层tau PET摄取相关,关联比p-tau181更广泛。
  • 血浆Aβ42/40联合p-tau231或p-tau181区分Aβ-PET阴性阳性,AUC范围0.81-0.86。
  • 血浆Aβ42/40低且p-tau高者,8年认知下降更快。

核心结论

  • 在症状前个体中,血浆p-tau231与PET生物标志物的关联比p-tau181更稳健。
  • p-tau与Aβ42/40联合可检测早期AD病理和认知下降,此类标志物可作为预筛工具以降低预防试验成本。

研究设计与样本

  • 研究纳入244名因阿尔茨海默病痴呆家族史而处于AD风险的认知正常老年人。
  • 检测Simoa血浆p-tau231、p-tau181和神经丝轻链,免疫沉淀质谱法检测Aβ40和Aβ42。
  • 其中129名参与者接受18F-NAV4694 Aβ-PET和18F-flortaucipir tau-PET评估。
  • 分析血浆标志物与全局及体素水平Aβ和tau PET的关联,并评估8年认知变化。

主要发现

  • 血浆p-tau标志物与flortaucipir在内侧颞叶、顶叶和颞下回区域的结合相关,p-tau231还与外侧顶叶和枕叶皮层相关。
  • 血浆Aβ42/40比单独Aβ42解释更多全局Aβ-PET结合方差。
  • 血浆p-tau231与皮层Aβ-PET结合呈强且广泛的关联。
  • Aβ42/40联合p-tau231或p-tau181区分Aβ阴性阳性参与者的AUC范围为0.81-0.86。
  • 血浆Aβ42/40低且p-tau高的个体认知下降更快。

临床怎么用

  • 作者认为,p-tau与Aβ42/40联合标志物可作为预筛工具用于减少预防试验成本。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to evaluate novel plasma p-tau231 and p-tau181, as well as Aβ40 and Aβ42 assays as indicators of tau and Aβ pathologies measured with positron emission tomography (PET), and their association with cognitive change, in cognitively unimpaired older adults. METHODS: In a cohort of 244 older adults at risk of Alzheimer's disease (AD) owing to a family history of AD dementia, we measured single molecule array (Simoa)-based plasma tau biomarkers (p-tau231 and p-tau181), Aβ40 and Aβ42 with immunoprecipitation mass spectrometry, and Simoa neurofilament light (NfL). A subset of 129 participants underwent amyloid-β (18 F-NAV4694) and tau (18 F-flortaucipir) PET assessments. We investigated plasma biomarker associations with Aβ and tau PET at the global and voxel level and tested plasma biomarker combinations for improved detection of Aβ-PET positivity. We also investigated associations with 8-year cognitive change. RESULTS: Plasma p-tau biomarkers correlated with flortaucipir binding in medial temporal, parietal, and inferior temporal regions. P-tau231 showed further associations in lateral parietal and occipital cortices. Plasma Aβ42/40 explained more variance in global Aβ-PET binding than Aβ42 alone. P-tau231 also showed strong and widespread associations with cortical Aβ-PET binding. Combining Aβ42/40 with p-tau231 or p-tau181 allowed for good distinction between Aβ-negative and -positive participants (area under the receiver operating characteristic curve [AUC] range = 0.81-0.86). Individuals with low plasma Aβ42/40 and high p-tau experienced faster cognitive decline. INTERPRETATION: Plasma p-tau231 showed more robust associations with PET biomarkers than p-tau181 in presymptomatic individuals. The combination of p-tau and Aβ42/40 biomarkers detected early AD pathology and cognitive decline. Such markers could be used as prescreening tools to reduce the cost of prevention trials. ANN NEUROL 2022;91:548-560.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Meyer PF, Ashton NJ, Karikari TK, et al. Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults. Ann Neurol. 2022. PMID: 35084051. doi:10.1002/ana.26308

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。